RYTM logo

Rhythm Pharmaceuticals, Inc. Common Stock


RYTM: Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.


Show RYTM Financials

Consumer Interest
SEC Filings

Recent trades of RYTM by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by RYTM's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of RYTM in WallStreetBets Daily Discussion


Recent insights relating to RYTM

CNBC Recommendations

Recent picks made for RYTM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RYTM

Corporate Flights

Flights by private jets registered to RYTM